Paid Clinical Trials in San Antonio, TX
Here are the 6 most popular medical studies in paid studies san antonio
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Placebo +1 More for Progressive Supranuclear Palsy
ORION Trial is a trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of a randomized double blind placebo controlled phase, followed by an optional open-label extension phase.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
SGN-CEACAM5C for Stomach Tumors
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts of your body, it's called metastatic. When a cancer has gotten so big it can't easily be removed or has spread to other parts of the body, it is called unresectable. These types of cancer are harder to treat. Patients in this study must have cancer that has come back or did not get better with treatment. Patients must have a solid tumor cancer that can't be treated with standard of care drugs. This clinical trial uses an experimental drug called SGN-CEACAM5C. SGN-CEACAM5C is a type of antibody-drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. They may also stick to some normal cells. This study will test the safety of SGN-CEACAM5C in participants with solid tumors that are hard to treat or have spread throughout the body. This study will have 3 parts. Part A and Part B of the study will find out how much SGN-CEACAM5C should be given to participants. Part C will use the information from Parts A and B to see if SGN-CEACAM5C is safe and if it works to treat solid tumor cancers.
ALTB-268 for Ulcerative Colitis
This trial will assess a new drug, ALTB-268, for safety and effectiveness in treating moderate to severe ulcerative colitis. Subjects will receive weekly doses for 12 weeks, followed by bi-weekly doses for 40 weeks.
Paid Clinical Trials
View 99 medical studies that offer remuneration.
BNT165e for Malaria
This is a randomized, dose-escalation Phase I/IIa trial to evaluate safety, tolerability, immunogenicity and efficacy of an investigational RNA-based vaccine (BNT165e) for prevention of P. falciparum malaria in healthy malaria-naive adults. The multi-antigen malaria vaccine (designated BNT165e) is a combination of three distinct RNAs, BNT165c and BNT165d (composed of BNT165d1 and BNT165d2), encoding P. falciparum antigens encapsulated in lipid nanoparticles (LNPs). The BNT165c RNA encodes the full Plasmodium falciparum circumsporozoite protein (PfCSP). The BNT165d1 and BNT165d2 RNAs both encode conserved, immunogenic segments of liver stage-expressed proteins.
View More Paid Studies San Antonio Trials
See another 76 many medical studies focused on paid studies san antonio.